US Congress House Bill 5939 (Prior Session Legislation)

---

Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on February 21 2020 - 25% progression, died in committee
Action: 2020-02-21 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Requires research and education activities related to triple-negative breast cancer. (The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein.) The National Institutes of Health must conduct and support research into the disease, and the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop and disseminate information about triple-negative breast cancer for the public and for health care providers, respectively. Among other topics, the information must cover the elevated risk for minority women and the availability of a range of treatment options for such cancers.

Triple-Negative Breast Cancer Research and Education Act of 2019

Rep. Sheila Jackson-Lee [D-TX]

Date	Chamber	Action
2020-02-21	House	Referred to the House Committee on Energy and Commerce.
2020-02-21	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/5939/all-info
Text	https://www.congress.gov/116/bills/hr5939/BILLS-116hr5939ih.pdf